Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

55.32 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,502
Open 55.32
Bid (Size) 55.80 (1)
Ask (Size) 56.13 (3)
Prev. Close 55.32
Today's Range 55.32 - 55.32
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Via Benzinga
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
It's a tough act to follow. 
Via The Motley Fool

Performance

YTD
+202.63%
+202.63%
1 Month
-11.16%
-11.16%
3 Month
-30.42%
-30.42%
6 Month
+202.63%
+202.63%
1 Year
+258.29%
+258.29%

More News

Read More
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
Via The Motley Fool
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
Via InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
Via InvestorPlace
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Via The Motley Fool
Viking Therapeutics Unusual Options Activity For June 25
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $600 Today
Via Benzinga
Viking Therapeutics Unusual Options Activity For June 12
Via Benzinga
Better Growth Stock: Archer Aviation or Viking Therapeutics?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
Via The Motley Fool
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
Via The Motley Fool
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%
Via The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
Via The Motley Fool
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
Via The Motley Fool
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks Quietly Preparing for a 10X Surge: June Edition
Via InvestorPlace
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
Via Investor's Business Daily
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Via The Motley Fool
This High-Flying Stock Just Announced More Good News: Time to Buy?
Via The Motley Fool
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.